COMMUNIQUÉS West-GlobeNewswire

GW Pharmaceuticals Reacquires Full Rights to Develop and Commercialize Sativex® in U.S.
13/12/2017
LONDON, Dec. 13, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]
National Research Corporation Announces Revised Class B Common Stock Recapitalization Plan
13/12/2017
All class B shares to be exchanged for one share of class A common stock plus $19.59 in cash, for total value of $53.44 per class B share Class A common stock to be sole outstanding security of the Company Previously [...]
Q Therapeutics Announces Research Collaboration With REPROCELL
13/12/2017
SALT LAKE CITY and YOKOHAMA, Japan, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) disease and injury, announced a collaborative [...]
Natus to Present at J.P. Morgan 36th Annual Healthcare Conference
13/12/2017
PLEASANTON, Calif., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY ) today announced that Jim Hawkins, President and Chief Executive Officer will present and Jonathan Kennedy, Executive Vice [...]
argenx announces size of proposed public offering in the United States updated to 3.5 million ADSs
13/12/2017
Regulated information - Inside information December 13, 2017 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of [...]
Photocure ASA: Presentation at the DNB Nordic Healthcare Conference, Oslo
13/12/2017
Oslo, Norway, December 13, 2017 - Photocure ASA (OSE: PHO) announces today that the company will present at the DNB Nordic Healthcare Conference on 14th of December 2017 in Oslo, Norway. Presenter will be Ambaw Bellete [...]
CORRECTION: Valerijs Maligins, Chairman of the Board of AS Olainfarm Has Passed Away - date changed
13/12/2017
Olaine, 2017-12-13 09:35 CET (GLOBE NEWSWIRE) -- Valerijs Maligins became Chairman of Olainfarm’s Board after the privatization of the company in 1997. Under his management, the company became one of the most valuable [...]
Update on C-RAD delivery of its advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna
13/12/2017
C-RAD announced in August that a contract to supply Nya Karolinska Solna (NKS) and Södersjukhuset in Stockholm, Sweden with its latest SIGRT (Surface Image Guided Radiation Therapy) solution was signed with Elekta [...]
Nexstim Plc's Financial Information in 2018
13/12/2017
Company announcement, Helsinki, 13 December 2017, at 9 am Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or the " Company "), a medical technology company developing and marketing pioneering navigated non-invasive [...]
Sanofi : Sanofi presents R&D strategy and innovative pipeline
13/12/2017
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi presents R&D strategy and innovative pipeline · Robust pipeline expected to support long-term growth · 9 planned regulatory submissions over next 18 [...]
Sanofi : Sanofi présente sa stratégie de R&D et son portefeuille innovant
13/12/2017
Sanofi présente sa stratégie de R&D et son portefeuille innovant · Un portefeuille robuste qui devrait soutenir la croissance à long terme · Neuf soumissions réglementaires planifiées au cours des 18 prochains mois [...]
Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma
13/12/2017
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma High and durable [...]
Sanofi et Regeneron annoncent les premiers résultats positifs d'une étude pivot consacrée à l'anticorps anti-PD-1 cemiplimab dans le traitement du carcinome épidermoïde cutané au stade avancé
13/12/2017
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi et Regeneron annoncent les premiers résultats positifs d'une étude pivot consacrée à l'anticorps anti-PD-1 cemiplimab dans le traitement du [...]
Targovax to present at DNB healthcare conference
13/12/2017
Oslo, Norway, 13 December 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that members of its senior management will present a [...]
Resverlogix Announces Voting Results From The 2017 Annual Meeting Of Shareholders
13/12/2017
CALGARY, Alberta, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX: RVX ) announced today that, at its annual meeting of shareholders held on December 12, 2017, Resverlogix [...]
House and Senate Agree: Palliative Care Matters!
12/12/2017
Surrey, BC, Canada, Dec. 12, 2017 (GLOBE NEWSWIRE) -- (Dec 12, 2017) In a time when House and Senate don’t always agree – it is refreshing that both groups voted “yes” to federal legislation to develop a framework for [...]
Dentsply Sirona Declares Quarterly Cash Dividend
12/12/2017
YORK, Pa., Dec. 12, 2017 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company TM , announced that its Board of Directors declared a quarterly cash dividend of $0. [...]
Telix Pharmaceuticals and JFE Announce Japanese Radiopharmaceutical Manufacturing Partnership
12/12/2017
MELBOURNE, Australia and TOKYO, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“ Telix ”, the “ Company ”), an Australian biopharmaceutical company focused on the development of diagnostic [...]
The Cooper Companies to Present at J.P. Morgan Healthcare Conference
12/12/2017
PLEASANTON, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) will present at the J.P. Morgan Healthcare Conference in San Francisco, Calif., on January 9, 2018. Robert S. Weiss, [...]

Pages